Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 Mar 20;20(7):969–978. doi: 10.1016/j.bbmt.2014.03.015

Figure 3. Effect of rFVIIa on ICU Length of Stay, Duration of Mechanical Ventilation, Resolution of Alveolar Hemorrhage, and Duration of Supplemental Oxygen Use.

Figure 3

In patients treated with rFVIIa plus conventional therapy (■) compared to patients treated with conventional therapy alone ( graphic file with name nihms578820ig1.jpg), there was no difference in ICU length of stay due to alveolar hemorrhage (AH; episodes included in analysis: rFVIIa n = 23/43, conventional therapy n = 8/14; p = 0.63), duration of mechanical ventilation (MV) due to AH (rFVIIa n = 25/43, conventional therapy n = 7/14; p = 0.89), time to resolution of AH (rFVIIa n = 30/43, conventional therapy n = 10/14; p = 0.50); or duration of supplemental oxygen use from the onset of the initial episode of AH (rFVIIa n = 23/23, conventional therapy n = 14/14; p = 0.55).